U.S. market Closed. Opens in 1 day 8 hours 36 minutes

SXTP | 60 Degrees Pharmaceuticals, Inc. Stock Financials Income Statements Annual

(Stock Exchange: NASDAQ)
*Sign In to persist settings
Financial Year End2023-12-312022-12-312021-12-312020-12-31
Revenue253.57K223.21K1.16M2.18M
Cost of Revenue474.55K432.37K850.74K702.99K
Gross Profit-220.98K-209.16K309.60K1.48M
Operating Expenses4.93M1.54M1.43M1.85M
Selling, General & Admin4.24M1.30M1.12M1.46M
Research & Development691.77K237.56K318.35K438.58K
Other Operating ExpensesN/A-43.24K37.52K-121.00
Operating Income-5.15M-1.75M-1.12M-418.13K
Other Expenses / Income1.34M-4.43M-3.14M-2.63M
Before Tax Income-3.81M-6.18M-4.26M-3.05M
Income Tax Expenses250.00500.001.00K1.00K
Net Income-3.77M-6.18M-4.25M-3.03M
Interest Expenses2.29M3.99M3.17M2.68M
Basic Shares Outstanding3.96M5.78M5.78M5.78M
Diluted Shares Outstanding3.96M5.78M5.78M5.78M
EBITDA-1.43M-2.11M-1.01M-341.17K
EBITDA Margin-562.58%-944.92%-87.46%-15.64%
EBIT-1.48M-2.19M-1.08M-354.31K
EBIT Margin-583.19%-981.98%-92.91%-16.24%
Financial Year End2023-12-312022-12-312021-12-312020-12-31
An error has occurred. This application may no longer respond until reloaded. Reload 🗙